Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-18Clinical Trial Update: Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects [Phase 4]
Phase 4 trial evaluating paricalcitol for calcitriol-resistant secondary hyperparathyroidism in dialysis patients was terminated, with resul…
-
FDA approval · 2010-06-11FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for ZEMPLAR (paricalcitol) from AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2010-05-04Clinical Trial Update: Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism [Phase 4]
This Phase 4 trial compares alfacalcidol to calcitriol for efficacy and safety in treating secondary hyperparathyroidism in patients with en…
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD) [Phase 2]
Phase 2 clinical trial evaluating treatment for secondary hyperparathyroidism in end-stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis [Phase 2]
Phase 2 dose-response study evaluating paricalcitol injection in chronic kidney disease patients on hemodialysis with secondary hyperparathy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Effects of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism
This clinical trial analyzes how parathyroidectomy affects cardiovascular risk factors in patients with primary hyperparathyroidism. The stu…
-
CLINICAL_TRIALS other · 2010-01-14Clinical Trial Update: Regulation of Bone Formation in Renal Osteodystrophy [Phase 2]
Clinical Trial Update reports the completion of a Phase 2 trial investigating regulation of bone formation in renal osteodystrophy sponsored…
-
CLINICAL_TRIALS trial_result · 2010-01-05Clinical Trial Update: Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects [NA]
A completed clinical trial evaluating oral peptone loading in adults with primary hyperparathyroidism and hypercalcemia, as well as healthy …
-
FDA approval · 2009-11-12FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)
The FDA approved Amgen's supplemental application for SENSIPAR (cinacalcet hydrochloride), resulting in updated labeling for the product.
-
FDA approval · 2009-08-20FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approves a supplemental application for ZEMPLAR (paricalcitol) submitted by AbbVie.
-
FDA approval · 2009-06-29FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for ZEMPLAR (paricalcitol) by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2009-05-20Clinical Trial Update: A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease [Phase 4]
Phase 4 trial evaluating Zemplar and Hectorol on intestinal calcium absorption in patients with end-stage renal disease and secondary hyperp…
-
EMA withdrawal · 2009-05-14EMA Withdrawn: Parareg (cinacalcet) — Dompé Biotec S.p.A.
EMA withdrawn status for Parareg (cinacalcet) by Dompé Biotec S.p.A., with therapeutic areas including hypercalcemia, parathyroid neoplasms,…
-
CLINICAL_TRIALS trial_result · 2009-04-08Clinical Trial Update: Open Versus Video-Assisted Minimal-Invasive Parathyroid Surgery [NA]
A completed clinical trial compared open versus video-assisted minimally invasive parathyroid surgery for primary hyperparathyroidism.
-
CLINICAL_TRIALS research · 2009-03-24Clinical Trial Update: Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism [Phase 1]
Phase 1 clinical trial evaluating energy-specific far infrared radiation treatment for Hyperparathyroidism. The update does not include tria…
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism [Phase 4]
Phase 4 trial evaluating a Sensipar (cinacalcet) treatment algorithm to reach K/DOQI targets in chronic kidney disease patients with seconda…
-
CLINICAL_TRIALS trial_result · 2009-01-26Clinical Trial Update: Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects [Phase 3]
Amgen's AMG 073 completed a Phase 3 trial evaluating safety and efficacy in adults with hyperparathyroidism undergoing hemodialysis.
-
FDA approval · 2008-12-19FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)
FDA approves a supplemental NDA for SENSIPAR (cinacalcet hydrochloride) submitted by Amgen, resulting in updated labeling and potential new/…
-
CLINICAL_TRIALS trial_result · 2008-08-11Clinical Trial Update: Calcium and Vitamin D Malnutrition in Elderly Women [Phase 3]
Phase 3 clinical trial update on calcium and vitamin D malnutrition in elderly women. The study has completed status and examines osteoporos…
-
FDA label_change · 2008-06-18FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA overview of AbbVie’s supplemental application for ZEMPLAR (paricalcitol) to update labeling.
-
FDA approval · 2008-02-28FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)
The FDA approved a supplemental application for SENSIPAR (cinacalcet hydrochloride) from Amgen.
-
CLINICAL_TRIALS trial_result · 2008-01-08Clinical Trial Update: CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients [Phase 4]
Phase 4 CARE-2 trial evaluating calcium acetate (PhosLo) and sevelamer (Renagel) for heart calcification in dialysis patients has completed.
-
CLINICAL_TRIALS research · 2007-12-28Clinical Trial Update: A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
A multi-center observational registry of subjects with secondary hyperparathyroidism and chronic kidney disease, completed to collect real-w…
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Post Transplant Study
Amgen's post-transplant clinical trial studying secondary hyperparathyroidism has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-08Clinical Trial Update: Interaction Between Anaesthetics and Methylene Blue
A completed clinical trial evaluating the interaction between methylene blue and anesthetic agents in hyperparathyroidism patients.